Ross Ajemian
Chalfont
Summary
A seasoned leader in Portfolio Analytics and Decision Sciences at GSK, I excel in strategic prioritization/planning, pipeline optimization/valuation analysis, while driving data-driven decision-making across 30+ programs. With a knack for senior stakeholder management and cross-functional collaboration, I've significantly enhanced R&D performance, embedding innovative analytical solutions to optimize global health outcomes.
Overview
18
18
years of professional experience
Work History
Global Health Portfolio Analytics Director
GSK
Collegeville
11.2023 - Current
- Embedded Decision Sciences capabilities by consistently providing data-driven insights to enhance decision-making for the underlying Global Health pipeline (30+ programs)
- This includes optimizing our investments in high priority discovery compounds, setting up dynamic portfolio reviews to reallocate resource in the hopes of accelerating milestones and inflection points, as well as framing emerging risks and opportunities to enable leadership to make trade-off decisions
- Partner with the preclinical Project Management community as well as Clinical Leads to collate accurate, up-to-date, and reliable pipeline information and present to senior stakeholders each month for milestone acceleration discussions
- Implemented a monthly governance context materials presentation that includes multi-decision criteria analysis (MCDA) to prioritize the portfolio across 5-10 criteria and over 30 active programs, providing strategic and analytical guidance for technical and investment governance boards as well as annual Portfolio Reviews
- Facilitated Probability of Technical and Regulatory Success (PTRS) workshops for the entire post-Candidate Selection pipeline and generated a fully risk-adjusted portfolio framework and efficiency frontier (20+ programs)
- Designed two Global Health Security ESG metrics and communications narratives for external annual reporting (tracking the number of progressed addressing WHO/CDC prioritized pathogens as well as ensuring a robust active pool of programs addressing critical//urgent anti-microbial resistance [AMR] pathogens)
- Lead the unit in developing innovative portfolio modeling solutions, including long-term Fill and Flow analysis, which embeds cycle time and PTRS benchmarks across more than ten diseases states
- Implemented the first of its kind Global Health Impact Model (GHIM), which models Deaths/DALY’s averted as a patient value measure (and a commercial surrogate for measuring ROI in the absence of sales inputs)
- Develop and track metrics assessing R&D performance, including tracking bonus assessment for R&D Pipeline Progression Objectives (PPO) across 15 high priority programs, which has enabled senior stakeholders to flexibly shift resource as needed and in the process achieve/surpass stretch targets for three consecutive years
- Support the shaping of strategic and operational reports on a constantly evolving R&D Portfolio
- Deliver timely and accurate standardized pipeline reports and ad hoc requests
Global Health Pipeline Analytics Manager
GSK
Collegeville
11.2021 - 11.2023
- Provide insightful leading metrics of GH Pipeline Progression Objectives tracking, and relevant news/events via high quality internal monthly reporting (Rx, Vx, Market Access, and GVGH Institute)
- Deliver succinct portfolio prioritization insights for annual governance as well as ad-hoc pipeline reviews across various disease areas to enable resource and strategic optimization
- Generated compelling insights and market research for the GH Access Ambition initiative, aimed at refocusing commercialized products on under-served L/LMIC countries
- Developed long term fill and flow pipeline model to enable investment trade-offs and optimization of portfolio focus
- Lead and facilitate Global Health PTRS workshops in preparation for monthly technical and strategic/investment governance
- Co-authored the Global Health Impact and Effectiveness Framework (GHIEF), a multi-criteria decision analysis tool to enable program differentiation and relevant SWOT analysis across the GH pipeline
- Leverage external benchmarking metrics and embed in portfolio discussions (ie - cycle time, PTRS, resource) for context/baselining
- Manage customers and business partner expectations and requirements with focus on value adding deliverables and continuous improvement
Portfolio Reporting/Analytics Manager
GSK
Collegeville
04.2018 - 11.2021
- Deliver high quality internal monthly reporting of pipeline to R&D leadership, providing insightful summaries of news/events and impact to confidence in projects, as well as providing accurate and succinct pipeline updates as requested by CET/Board
- Provide technical leadership and analytical support in Research/Global Health PTRS estimation in preparation for RRB and RIB as well as valuation of clinical programs in preparation for Development Review Board and Portfolio Investment Board
- Provide accurate annual Research Investment Board/Portfolio Investment Board pipeline input
Finance Manager
GSK
Collegeville
02.2015 - 02.2018
- Supported the Future Pipeline Discovery/Global Health business providing financial analysis and insight enabling decisions around optimizing resource, managing risks/opportunities, delivering on financial targets and annual fill & flow milestones
- Lead Finance Partner support for 5 Discovery Performance Units (DPU’s) and Global Health clinical portfolio
Pipeline Decision Support & Analytics Manager
GSK
Collegeville
02.2012 - 02.2015
- Coordinated the annual budgeting and monthly forecasting, business reporting and consolidation process for 15+ business units
- Develop targets, key metrics, and multi-year financial projections
- Key Finance Reporting member for various R&D Investment/Governance Boards (both Early/Late Stage strategy)
Senior Financial FP&A Analyst
GSK
Collegeville
03.2009 - 02.2012
- Led budgeting and forecasting across 5+ units and provided insightful month-end analysis to senior management
- Worked closely with senior management to craft budgetary guidelines to enable close proximity to target goals
Hedge Fund Supervisor
SEI Corporation
Oaks
08.2007 - 03.2009
- Led in the research, analysis, presentations and portfolio recommendations representing $100m in assets
Education
MBA - Finance
Suffolk University
Boston, MA05.2006
BS - Marketing
Fairfield University
Fairfield, CT05.2003
Skills
- Excels in cross-functional team settings
- Strategic planning
- Financial analysis
- Multi Criteria Decision Analysis (MCDA) experience
- Financial and commercial modeling
- Senior stakeholder management
- Strong collaboration skills
- Industry knowledge
- Corporate social responsibility
Timeline
Global Health Portfolio Analytics Director
GSK
11.2023 - Current
Global Health Pipeline Analytics Manager
GSK
11.2021 - 11.2023
Portfolio Reporting/Analytics Manager
GSK
04.2018 - 11.2021
Finance Manager
GSK
02.2015 - 02.2018
Pipeline Decision Support & Analytics Manager
GSK
02.2012 - 02.2015
Senior Financial FP&A Analyst
GSK
03.2009 - 02.2012
Hedge Fund Supervisor
SEI Corporation
08.2007 - 03.2009
MBA - Finance
Suffolk University
BS - Marketing
Fairfield University
Similar Profiles
Sarah MellorSarah Mellor
Product Manager, NUCALA at GSKProduct Manager, NUCALA at GSK
Patricia MontgomeryPatricia Montgomery
Executive Assistant, Vice President at GSKExecutive Assistant, Vice President at GSK
RYANNE KOSICKRYANNE KOSICK
Marketing Manager Hematology Oncology at GSKMarketing Manager Hematology Oncology at GSK